Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-16), Encompass Health's 14-Day RSI is 100.00.
The industry rank for Encompass Health's 14-Day RSI or its related term are showing as below:
MEX:EHC's 14-Day RSI is ranked worse than 83.36% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 50.03
vs MEX:EHC: 100.00
Encompass Health (MEX:EHC) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Encompass Health 14-Day RSI Related Terms
MEX:EHC vs ENSG, UHS, PACS: 14-Day RSI Comparison
For the Medical Care Facilities subindustry, Encompass Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Encompass Health 14-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Encompass Health's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Encompass Health (MEX:EHC) has a 14-Day RSI of 100.00 as of Jul. 16, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Encompass Health and its competitors. According to the industry distribution chart, Encompass Health ranks #581 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 83.4%.
Is Encompass Health's 14-Day RSI too high?
Encompass Health's current 14-Day RSI is 100.00. The Healthcare Providers & Services industry median 14-Day RSI is 50.03. Encompass Health's value of 100.00 is 99.9% above this industry median. Based on the distribution chart, Encompass Health ranks #581 out of 697 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Encompass Health has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Encompass Health's 14-Day RSI compare to ENSG and UHS?
According to the Healthcare Providers & Services industry distribution chart, Encompass Health ranks #581 out of 697 companies for 14-Day RSI. This places Encompass Health in the lower half of its industry. The industry median 14-Day RSI is 50.03. Encompass Health's value of 100.00 is 99.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Healthcare Providers & Services company?
The median 14-Day RSI among Healthcare Providers & Services companies is 50.03, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Encompass Health's current 14-Day RSI of 100.00 is 99.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Encompass Health and its competitors. For the Healthcare Providers & Services industry, the median 14-Day RSI is 50.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Encompass Health's current 14-Day RSI is 100.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encompass Health stock overvalued right now?
Based on GuruFocus' analysis, Encompass Health (MEX:EHC) is currently considered Fairly Valued. The stock's GF Value™ is MXN1,970.57, compared to a current price of MXN1,930.00 — trading 2.1% below its estimated fair value. The current 14-Day RSI is 100.00 and 99.9% above the Healthcare Providers & Services industry median of 50.03. Encompass Health's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Encompass Health (MEX:EHC), the current 14-Day RSI is 100.00 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Encompass Health (MEX:EHC) Overvalued in 2026?
Based on GuruFocus' analysis, Encompass Health stock appears to be undervalued.
The current stock price of MXN1,930.00 is trading 2.1% below its estimated GF Value™ of MXN1,970.57.
GuruFocus considers Encompass Health to be Fairly Valued.
Key valuation signals for MEX:EHC:
14-Day RSI: 100.00
GF Value™: MXN1,970.57 vs. price of MXN1,930.00 (2.1% below fair value)
Industry Position: 99.9% above the Healthcare Providers & Services median (#581 of 697)
No single metric tells the full story. See the MEX:EHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
76GF Score
Get the complete analysis for MEX:EHC
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EHC has been successfully added to your 
